Cargando…

Point-of-Care Tests for HIV Drug Resistance Monitoring: Advances and Potentials

HIV/AIDS is a global public health crisis that is yet to be contained. Effective management of HIV drug resistance (HIVDR) supported by close resistance monitoring is essential in achieving the WHO 95-95-95 targets, aiming to end the AIDS epidemic by 2030. Point-of-care tests (POCT) enable decentral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chua, Rayeil J., Capiña, Rupert, Ji, Hezhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321160/ https://www.ncbi.nlm.nih.gov/pubmed/35889970 http://dx.doi.org/10.3390/pathogens11070724

Ejemplares similares

Bioinformatic data processing pipelines in support of next‐generation sequencing‐based HIV drug resistance testing: the Winnipeg Consensus
por: Ji, Hezhao, et al.
Publicado: (2018)

Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada
por: Ji, Hezhao, et al.
Publicado: (2018)

HIV drug resistance testing – The quest for Point-of-Care
por: Noguera-Julian, Marc
Publicado: (2019)

External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges
por: Lee, Emma R., et al.
Publicado: (2020)

Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing
por: Noguera-Julian, Marc, et al.
Publicado: (2020)

Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium
por: Ji, Hezhao, et al.
Publicado: (2020)

Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing
por: Jennings, Cheryl, et al.
Publicado: (2020)

Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing
por: Ji, Hezhao, et al.
Publicado: (2022)

A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance
por: Taylor, Tracy, et al.
Publicado: (2019)

Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing
por: Lee, Emma R., et al.
Publicado: (2020)

Current Research on HIV Drug Resistance—A Topical Collection with “Pathogens”
por: Ji, Hezhao
Publicado: (2022)

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing
por: Rhee, Soo-Yon, et al.
Publicado: (2015)

Pre-treatment HIV drug resistance testing cost-effectiveness
por: van de Vijver, David AMC, et al.
Publicado: (2020)

Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations
por: Ávila-Ríos, Santiago, et al.
Publicado: (2020)

Where we are with point-of-care testing
por: Johannessen, A
Publicado: (2015)

Pertussis: Point-of-Care Testing in the Making
por: Wirsing von Koenig, Carl Heinz
Publicado: (2019)

Improving the Quality of Diagnostic Studies Evaluating Point of Care Tests for Acute HIV Infections: Problems and Recommendations
por: Smallwood, Megan, et al.
Publicado: (2017)

Probe Capture Enrichment Methods for HIV and HCV Genome Sequencing and Drug Resistance Genotyping
por: Munyuza, Chantal, et al.
Publicado: (2022)

A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples
por: Gupta, Shivani, et al.
Publicado: (2017)

External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations
por: Ji, Hezhao, et al.
Publicado: (2020)

Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework
por: Capina, Rupert, et al.
Publicado: (2020)

Rapid Point-of-Care Testing for Detection of HIV and Clinical Monitoring
por: Arora, D. R., et al.
Publicado: (2013)

HIV Drug Resistance Surveillance Using Pooled Pyrosequencing
por: Ji, Hezhao, et al.
Publicado: (2010)

HIV Drug Resistance in Resource-limited Countries: Threat for HIV Elimination
por: Ngo-Giang-Huong, Nicole, et al.
Publicado: (2019)

In vitro tests for drug resistance in Plasmodium falciparum
por: Wernsdorfer, Walther H.
Publicado: (2012)

Quality assurance for HIV point-of-care testing and treatment monitoring assays
por: Meyers, Adrienne F.A., et al.
Publicado: (2016)

Pharmacy-Based Point-of-Care Testing: How a “Standard of Care” Approach Can Facilitate Sustainability
por: Adams, Alex J., et al.
Publicado: (2021)

The future of iron deficiency diagnostics – Rapid home-use point-of-care test kits
por: Meybohm, Patrick
Publicado: (2019)

Identification and validation of host biomarkers for leprosy: A step forward to establish point-of-care tests
por: Nausch, Norman, et al.
Publicado: (2019)

Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis
por: Rönn, Minttu M, et al.
Publicado: (2020)

Following the path: Increasing trends of HIV-1 drug resistance in China
por: Gupta, Soham, et al.
Publicado: (2020)

A Comparison of Parallel Pyrosequencing and Sanger Clone-Based Sequencing and Its Impact on the Characterization of the Genetic Diversity of HIV-1
por: Liang, Binhua, et al.
Publicado: (2011)

The contribution of HIV point-of-care tests in early HIV diagnosis: community-based HIV testing monitoring in Catalonia, 1995 to 2018
por: Fernàndez-López, Laura, et al.
Publicado: (2020)

Approaches for improving linkage to HIV care among HIV self-testing individuals in sub-Saharan Africa
por: Hlongwa, Mbuzeleni, et al.
Publicado: (2023)

Some relevant points on sperm DNA fragmentation tests
por: Muratori, Monica, et al.
Publicado: (2017)

Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic
por: Nguyen, Trieu, et al.
Publicado: (2021)

Minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: An integrated approach for multidrug-resistant tuberculosis
por: Srivastava, Shashikant
Publicado: (2015)

Point/counterpoint: Cerebrovascular resistance is a flawed concept
por: Ince, Jonathan, et al.
Publicado: (2023)

Therapeutic drug monitoring: linezolid too?
por: Richards, Guy A, et al.
Publicado: (2014)

The Clinical Utility of Point-of-Care Tests for Influenza in Ambulatory Care: A Systematic Review and Meta-analysis
por: Lee, Joseph Jonathan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lmj7b4bfhbqv38f4ehds7kdpe4